Enhanced Monitoring System to Better Monitor High-Risk COVID-19 Patients

被引:0
|
作者
Thong Chuan Eugene Koh
Jia Yi Goh
Wen Kien Joachim Yau
Ta Wei Kevin Kok
Martin Yong Kwong Lee
Kelvin C. Y. Goh
Meng Wah Sng
Si Jack Chong
机构
[1] Ministry of Health (Crisis Strategy Operations Group),
[2] Singapore Armed Forces (HQ Medical Corps),undefined
来源
关键词
Telemedicine; Productivity; Monitoring; High-Risk patients; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
Telemedicine (TM) is a useful tool to extend medical care during a pandemic. TM was extensively utilized in Singapore during the COVID-19 pandemic as part of the Nation’s COVID-19 healthcare strategy. Patients were risk stratified to prioritize limited healthcare resources and the Telemedicine Allocation Reconciliation System (TMARS) was adapted to monitor and manage limited TM resources. High-Risk patients (Protocol 1) had an escalation rate of 4.87%, compared to the non-High-Risk patients’ 0.002% and TM doctors spent an average of six hours to complete one tele-consultation. In order to optimize the efficiency of the TM system, an enhanced monitoring system was implemented in March 2022. The intent was to focus monitoring efforts on the High-Risk patients. High-Risk patients reporting sick for the first time were prioritized to receive tele-consultations through this system. With the aid of a data-driven dashboard, the Operations Control and Monitoring team (OCM) was able to closely monitor the performance of the various TM providers (TMPs), sent them timely reminders and re-assigned patients to other TMPs when the requisite turnaround time was not met. Implementing the enhanced monitoring system resulted in a significant reduction in the average time taken to provide tele-consultations. After 3 months of implementation, the percentages of consultations completed within two hours were raised from 75.7% (February 2022) to 96.8% (May 2022), greatly increasing productivity and efficiency.
引用
收藏
相关论文
共 50 条
  • [41] Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic
    Janczewski, Lauren M.
    Browner, Amanda E.
    Cotler, Joseph H.
    Palis, Bryan E.
    Chan, Kelley
    Joung, Rachel H.
    Bentrem, David J.
    Merkow, Ryan P.
    Boffa, Daniel J.
    Nelson, Heidi
    [J]. JAMA NETWORK OPEN, 2024, 7 (03) : E240160
  • [42] Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients
    Birk, Navina K.
    Jain, Saniya
    Massoud, Louis
    Ramesh, Diya
    Monday, Lea
    Muma, Bruce
    Williams, Jonathan
    Alangaden, George
    Ramesh, Mayur
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [43] MoniCovid: Monitoring System for Patients with Symptoms of COVID-19
    Reyes, Brayanm
    Manrique, Alvaro
    Herrera, Emilio
    [J]. 2022 17TH IBERIAN CONFERENCE ON INFORMATION SYSTEMS AND TECHNOLOGIES (CISTI), 2022,
  • [44] Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
    Carolin E. M. Jakob
    Ujjwal Mukund Mahajan
    Marcus Oswald
    Melanie Stecher
    Maximilian Schons
    Julia Mayerle
    Siegbert Rieg
    Mathias Pletz
    Uta Merle
    Kai Wille
    Stefan Borgmann
    Christoph D. Spinner
    Sebastian Dolff
    Clemens Scherer
    Lisa Pilgram
    Maria Rüthrich
    Frank Hanses
    Martin Hower
    Richard Strauß
    Steffen Massberg
    Ahmet Görkem Er
    Norma Jung
    Jörg Janne Vehreschild
    Hans Stubbe
    Lukas Tometten
    Rainer König
    [J]. Infection, 2022, 50 : 359 - 370
  • [45] Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
    Jakob, Carolin E. M.
    Mahajan, Ujjwal Mukund
    Oswald, Marcus
    Stecher, Melanie
    Schons, Maximilian
    Mayerle, Julia
    Rieg, Siegbert
    Pletz, Mathias
    Merle, Uta
    Wille, Kai
    Borgmann, Stefan
    Spinner, Christoph D.
    Dolff, Sebastian
    Scherer, Clemens
    Pilgram, Lisa
    Ruethrich, Maria
    Hanses, Frank
    Hower, Martin
    Strauss, Richard
    Massberg, Steffen
    Er, Ahmet Gorkem
    Jung, Norma
    Vehreschild, Joerg Janne
    Stubbe, Hans
    Tometten, Lukas
    Koenig, Rainer
    [J]. INFECTION, 2022, 50 (02) : 359 - 370
  • [46] Glycaemic monitoring and control among high-risk patients with type 2 diabetes in Australian general practice during COVID-19
    Barlow, Kirrilee Jane
    Fahey, Paul P.
    Atlantis, Evan
    [J]. FAMILY MEDICINE AND COMMUNITY HEALTH, 2023, 11 (03)
  • [47] Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality
    Haddad, Tufia C.
    Coffey, Jordan D.
    Deng, Yihong
    Glasgow, Amy E.
    Christopherson, Laura A.
    Sangaralingham, Lindsey R.
    Bell, Sarah J.
    Shah, Vishal P.
    Pritchett, Joshua C.
    Orenstein, Robert
    Speicher, Leigh L.
    Maniaci, Michael J.
    Ganesh, Ravindra
    Borah, Bijan J.
    [J]. MAYO CLINIC PROCEEDINGS, 2022, 97 (12) : 2215 - 2225
  • [48] How to monitor the brain in COVID-19 patients?
    Peluso, Lorenzo
    Minini, Andrea
    Taccone, Fabio Silvio
    [J]. INTENSIVE AND CRITICAL CARE NURSING, 2021, 63
  • [49] Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis
    Gianotti, Raffaele
    Coggi, Antonella
    Boggio, Francesca
    Fellegara, Giovanni
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 1 - 5
  • [50] Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
    Lee, Ji Yeon
    Lee, Jee Young
    Ko, Jae-Hoon
    Hyun, Miri
    Kim, Hyun Ah
    Cho, Seongcheol
    Lee, Yong Dae
    Song, Junghoon
    Shin, Seunghwan
    Peck, Kyong Ran
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12